Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
出版年份 2021 全文链接
标题
Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
作者
关键词
Acute respiratory distress syndrome (ARDS), SARS-CoV, MERS-CoV, SARS-CoV-2, COVID-19, Cytokine storm, Immunomodulators, Immunotherapeutics
出版物
SAUDI PHARMACEUTICAL JOURNAL
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-01-10
DOI
10.1016/j.jsps.2020.12.018
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronavirus infections and immune responses
- (2020) Geng Li et al. JOURNAL OF MEDICAL VIROLOGY
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates
- (2020) Steffen Mueller et al. VACCINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
- (2020) Junxiong Pang et al. Journal of Clinical Medicine
- Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
- (2020) Balamurugan Shanmugaraj et al. Pathogens
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- COVID-19 treatment by repurposing drugs until the vaccine is in sight
- (2020) Mrudula Phadke et al. DRUG DEVELOPMENT RESEARCH
- Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset
- (2020) Bin Lou et al. EUROPEAN RESPIRATORY JOURNAL
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
- (2020) Ling Ni et al. IMMUNITY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
- (2020) Paul Kellam et al. JOURNAL OF GENERAL VIROLOGY
- Profile of specific antibodies to SARS-CoV-2: The first report
- (2020) Ai Tang Xiao et al. JOURNAL OF INFECTION
- Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
- (2020) Fan Wang et al. JOURNAL OF INFECTIOUS DISEASES
- From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
- (2020) Mahmoud Kandeel et al. JOURNAL OF MEDICAL VIROLOGY
- COVID-19 and immunomodulator/immunosuppressant use in dermatology
- (2020) Kyla N. Price et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Why tocilizumab could be an effective treatment for severe COVID-19?
- (2020) Binqing Fu et al. Journal of Translational Medicine
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
- (2020) Barry Rockx et al. SCIENCE
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
- (2020) Eun Kim et al. EBioMedicine
- IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
- (2020) Andrea Padoan et al. CLINICA CHIMICA ACTA
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19: Melatonin as a potential adjuvant treatment
- (2020) Rui Zhang et al. LIFE SCIENCES
- SARS-CoV-2 Vaccine Development: Current Status
- (2020) Gregory A. Poland et al. MAYO CLINIC PROCEEDINGS
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
- (2020) Vibhuti Kumar Shah et al. Frontiers in Immunology
- Immune response in COVID-19: A review
- (2020) Mohammad Asaduzzaman Chowdhury et al. Journal of Infection and Public Health
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust
- (2020) Jason L. Schwartz NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets
- (2019) Charles B. Stauft et al. PLoS One
- Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study
- (2019) Akbar K Waljee et al. Lancet Gastroenterology & Hepatology
- Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
- (2018) Sofia E. Magnusson et al. IMMUNOLOGIC RESEARCH
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
- (2017) Vincent J. Munster et al. npj Vaccines
- Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools
- (2016) Jared Klarquist et al. MEDIATORS OF INFLAMMATION
- Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice
- (2016) Karin Lövgren Bengtsson et al. VACCINE
- An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
- (2015) B. L. Haagmans et al. SCIENCE
- Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
- (2014) Ying Wang et al. NATURE IMMUNOLOGY
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
- (2014) Christopher M. Coleman et al. VACCINE
- Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
- (2013) L. Du et al. JOURNAL OF VIROLOGY
- Exposure to Nicotine Adversely Affects the Dendritic Cell System and Compromises Host Response to Vaccination
- (2012) M. Nouri-Shirazi et al. JOURNAL OF IMMUNOLOGY
- Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response
- (2012) Yan Li et al. MICROBES AND INFECTION
- Regulatory T Cells in Arterivirus and Coronavirus Infections: Do They Protect Against Disease or Enhance it?
- (2012) Thomas E. Cecere et al. Viruses-Basel
- Recent insights into the role of Toll-like receptors in viral infection
- (2010) M. Carty et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Intracellular Toll-like Receptors
- (2010) Amanda L. Blasius et al. IMMUNITY
- Antiviral CD8+T cell effector activities in situ are regulated by target cell type
- (2010) Matthew M. Hufford et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Recognition of 5′ Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand Virus
- (2009) Martin Schlee et al. IMMUNITY
- Inflammasome recognition of influenza virus is essential for adaptive immune responses
- (2009) Takeshi Ichinohe et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In situ imaging reveals different responses by naïve and memory CD8 T cells to late antigen presentation by lymph node DC after influenza virus infection
- (2008) Kamal M. Khanna et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now